Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
107Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $972.02M | $-198.70M | $-0.33 |
| 2024 | $995.55M | $-2.41B | $-4.02 |
| 2023 | $871.80M | $-556.48M | $-0.93 |
| 2022 | $1.54B | $902.60M | $1.50 |
| 2021 | $1.54B | $656.02M | $1.11 |
Social Signal Score
Earnings
Typical surprise -5.3% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Feb 26$0.18 vs $0.15beat
- Thu, Oct 30$0.13 vs $0.16miss
- Thu, Jul 31$0.14 vs $0.15miss
- Thu, May 1$0.14 vs $0.15miss
- Thu, Feb 27$0.18 vs $0.16beat
- Thu, Nov 7$0.16 vs $0.20miss
Estimates and results for MPW via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MPWhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsseekingalpha.com·3d ago·Neutral
Medical Properties Trust Remains Absurdly Priced, Offers Significant Upside Medical Properties Trust remains a 'strong buy' despite recent share price declines and investor frustration over debt refinancing. Revenue growth, driven by successful retenanting and acquisitions, outpaced analyst expectations, while cash flow and adjusted FFO metrics improved year-over-year. MPW's debt refinancing increases interest expense but reduces net debt and extends maturities, with book value per share decline
View source ↗
